Five things you didn’t know about off-label sales compliance
Posted 27th September 2011 in Articles, General | Register to comment
Maureen Shaffer shares her tips on off-label sales compliance.
Off-label sales compliance is difficult. There is subtlety to staying on message. Pharma sales representatives are highly mobile and verbal. Compliance and…
Read the full articleExpert review: doing business in the Nordics
Posted 27th September 2011 in Articles, Commercial | Register to comment
With the Nordics representing a significant business opportunity for many pharma companies, Frode Hellesnes offers some pearls of wisdom for those contemplating entering the Nordic markets.
Some 24.5 million inhabitants are living in the four main countries in the Nordics: Denmark, Finland, Norway and Sweden. If one also includes…
Read the full articleSocial pharma faces: Andrew Widger
Posted 26th September 2011 in Articles, Interviews | Register to comment
Continuing our series speaking with the people driving pharma social media engagement, we catch up with Andrew Widger from Pfizer for another perspective from inside big pharma.
This time on “pharma social faces” pharmaphorum speaks to Andrew Widger, from Pfizer’s EMEA communications team about his experience with …
Read the full articlemHealth Monthly Mashup: release 4.0 – how mHealth is revolutionizing emergency services
Posted 23rd September 2011 in Articles, General | Register to comment
Checking in to his next instalment in the series, Michael Spitz shares how the unique qualities of mobile devices lend themselves to helping optimize emergency services alerts and response.
Well before the advent of tablets and smartphones, emergency physicians led the mHealth charge by utilizing suites of nascent software products from their…
Read the full articlePharma emerging markets: where does Latin America stand regarding phase IV?
Posted 23rd September 2011 in Articles, Interviews | Register to comment
Valentina Jaramillo highlights the potential of Latin America in phase IV studies.
In past articles we have discussed the potential for Latin America in the clinical trial business in general but this time I want to…
Read the full articleCan increased transparency lead to trust in the industry?
Posted 22nd September 2011 in Articles, Conferences | Register to comment
pharmaphorum reports on the recent Strategic MedComms Forum 2011 to find out steps we can take to increase transparency and trust in the industry.
Trust in the pharmaceutical industry in clearly lacking. Given that trust in pharma contributes hugely to public health, this is a…
Read the full articleGlobal biosimilars market – a myriad of promises
Posted 22nd September 2011 in Articles, General | Register to comment
Shushmul Maheshwari takes us on a global journey exploring the potential of biosimilars across different geographic regions.
Biosimilars, also known as ‘biogenerics’ or ‘follow-on biologics’, have become a talk of the industry in recent years, following the patent expiry of…
Read the full articlePharma gets social: GlaxoSmithKline embraces facebook engagement
Posted 21st September 2011 in Articles, Commercial | Register to comment
In the first of a new series looking at pharma’s involvement in social media Daniel Ghinn discusses GSK’s involvement with facebook.
Amongst professionals in pharmaceutical companies there are mixed feelings about social media, and opinions differ as to whether it is…
Read the full articleUsing the metabolic mindset to boost healthcare provider confidence in your brand
Posted 20th September 2011 in Articles, General | Register to comment
Jessica Brueggeman highlights how behaviour patterns can determine how patients will respond to treatment approaches. Is it time we stopped to recognise our patients’ motivations rather than apply a one-size-fits-all approach?
Chronic, non-communicable diseases pose a serious burden to patients, healthcare providers and healthcare systems. While patients’ interactions…
Read the full articleSocial pharma faces: Kai Gait
Posted 19th September 2011 in Articles, Interviews | Register to comment
Speaking with Kai Gait, pharmaphorum gets a taste of how the benefits of social media for pharma can only be realised with a clear understanding of the customer.
The latest in our social pharma faces interview series sees us speaking with digital marketing professional, Kai Gait. Kai offers a wealth of knowledge…
Read the full article